Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

SRx Health Solutions (SRXH) FCF Margin (2016 - 2025)

SRx Health Solutions' FCF Margin history spans 10 years, with the latest figure at 137.54% for Q2 2025.

  • For Q2 2025, FCF Margin fell 13079.0% year-over-year to 137.54%; the TTM value through Sep 2025 reached 36.78%, down 2921.0%, while the annual FY2023 figure was 0.2%, 3817.0% up from the prior year.
  • FCF Margin reached 137.54% in Q2 2025 per SRXH's latest filing, down from 5.27% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 17.24% in Q4 2023 to a low of 137.54% in Q2 2025.
  • Average FCF Margin over 5 years is 22.87%, with a median of 20.47% recorded in 2024.
  • Peak YoY movement for FCF Margin: surged 4509bps in 2023, then plummeted -13079bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 34.29% in 2021, then grew by 19bps to 27.85% in 2022, then surged by 162bps to 17.24% in 2023, then tumbled by -56bps to 7.62% in 2024, then plummeted by -1905bps to 137.54% in 2025.
  • Per Business Quant, the three most recent readings for SRXH's FCF Margin are 137.54% (Q2 2025), 5.27% (Q1 2025), and 7.62% (Q4 2024).